Table 5.

Optimized Statistical Models Used for the Assessment of the Potential Risk of the Occurrence of nVT Episodes in Holter Monitoring

(a) Preexercise/(HM1): Assessment of the Potential Risk of the Occurrence of Spontaneous nVT Episodes (nVT1)
Variables	Model without TWA OR (95% CI)	Model with TWA OR (95% CI)
LP1	3.70 (1.02–13.51)	2.16 (0.49–9.51)
QTc 1	1.03 (1.01–1.42)	1.02 (1.00–1.42)
TWA+		2.76 (0.72–10.50)
(b) Postexercise (HM2): Assessment of the Potential Risk of the Occurrence of Postexercise nVT Episodes
Variables	Model without TWA OR (95% CI)	Model with TWA OR (95% CI)
NT‐proBNP	1.06 (1.00–1.41)	1.01 (1.00–1.40)
QTc 2	1.04 (1.00–1.52)	1.02 (0.96–1.51)
TWA+		4.04 (0.88–18.5)

LP = ventricular late potentials; NT‐proBNP = N‐terminal precursor of brain natriuretic peptide; QTc = corrected QT interval.